SuperworthAbvc Biopharma shares outstanding ABVC
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 26.1M
- On a year earlier
- +49.9%
- more shares
Abvc Biopharma had 26.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 49.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 24.7M | +87% |
| FY2024 | 13.2M | +98% |
| FY2023 | 6.7M | +101% |
| FY2022 | 3.3M | +32% |
| FY2021 | 2.5M | +23% |
| FY2020 | 2M | +13% |
| FY2019 | 1.8M | +67% |
| FY2018 | 1.1M | −9% |
| FY2017 | 1.2M | +0% |
| FY2017 | 1.2M | +43% |
| FY2016 | 832.8K | +1372859% |
| FY2013 | 61 | +1% |
| FY2012 | 60 | +385% |
| FY2011 | 12 | +70% |
| FY2010 | 7 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 26.1M | +50% | |
| Q1 FY26 | 25.4M | +70% | |
| Q4 FY25 | 24.7M | +87% | |
| Q3 FY25 | 23.3M | +87% | |
| Q2 FY25 | 17.4M | +54% | |
| Q1 FY25 | 15M | +54% | |
| Q4 FY24 | 13.2M | +98% | |
| Q3 FY24 | 12.4M | +206% | |
| Q2 FY24 | 11.3M | +242% | |
| Q1 FY24 | 9.7M | +194% | |
| Q4 FY23 | 6.7M | +101% | |
| Q3 FY23 | 4.1M | +24% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Abvc Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.